Clolar clofarabine regulatory update

Genzyme said FDA's Oncologic Drugs Advisory Committee will discuss an sNDA for Clolar clofarabine to treat acute myeloid leukemia (AML) in untreated patients ages 60 and up with at least 1 unfavorable...